Skip to main content
. 2019 May 30;3(1):e000470. doi: 10.1136/bmjpo-2019-000470

Table 5.

Comorbidity and poor birth outcome for mild microcephaly versus normocephaly

Mortality/morbidity Mild microcephaly
(n=2102)
Normocephaly
(n=42 034)
OR
Infants (n) Prevalence per 1000 Infants (n) Prevalence per 1000 Unadjusted OR
(95% CI)
Adjusted OR*
(95% CI)
In-hospital mortality 5 2.0 85 2.0 1.18 (0.48 to 2.90) 1.21 (0.49 to 3.00)
Preterm (33–36 weeks) 80 38.4 3470 82.6 0.45 (0.36 to 0.55) 0.45 (0.35 to 0.56)
1 min Apgar score <8 45 21.4 939 22.3 0.96 (0.71 to 1.30) 0.98 (0.72 to 1.33)
5 min Apgar score <8 6 2.9 141 3.4 0.85 (0.38 to 1.93) 0.83 (0.37 to 1.90)
Necrotising enterocolitis 3 1.6 49 1.2 1.23 (0.38 to 3.93) 1.26 (0.39 to 4.05)
Intracranial haemorrhage 9 3.2 125 3.0 1.44 (0.73 to 2.84) 1.58 (0.80 to 3.15)
Bronchopulmonary dysplasia 1 0.4 21 0.5 0.95 (0.13 to 7.08) 1.03 (0.14 to 8.04)
Birth hypoxia 35 16.2 594 14.1 1.18 (0.84 to 1.67) 1.21 (0.85 to 1.71)
Feeding difficulties 103 55.0 2243 53.4 0.91 (0.75 to 1.12) 0.89 (0.72 to 1.09)
Signs of seizure 1 0.5 27 0.7 0.74 (0.33 to 5.63) 0.76 (0.34 to 5.66)
Sepsis of newborn 5 2.4 90 2.1 1.11 (0.45 to 2.74) 1.09 (0.44 to 2.68)
Respiratory distress syndrome 14 6.3 435 10.3 0.64 (0.38 to 1.09) 0.71 (0.42 to 1.22)
Length of stay >7 days† 197 93.7 3916 93.2 1.01 (0.87 to 1.17) 1.07 (0.91 to 1.39)
Length of stay (mean±SD, day) 3.84±3.66 3.97±3.21 P=0.11

*Models contain mild microcephaly (vs normocephaly) as the exposure, and birth issues as outcomes, and are adjusted for infant gender, parity, maternal age, ethnicity, education, TORCH agents, exposure to teratogens, pre-eclampsia, diabetes mellitus and chronic illness.

†Infant in-hospital deaths were excluded for the calculation of length of stay.

TORCH, Toxoplasma gondii, rubella virus, cytomegalovirus, herpes simplex virus.